Krishnan Arunkumar, Nijmeijer Saskia, de Graaf Chris, Schiöth Helgi B
Department of Neuroscience, Functional Pharmacology, Uppsala University, Biomedical Center, 593, Uppsala, 75 124, Sweden.
Department of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, 1081HV, The Netherlands.
Handb Exp Pharmacol. 2016;234:15-41. doi: 10.1007/978-3-319-41523-9_2.
Representation of the nine distinct aGPCR subfamilies and their unique N-terminal domain architecture. The illustration also shows the extracellular structural feature shared by all aGPCRs (except ADGRA1), known as the GPCR autoproteolysis-inducing (GAIN) domain, that mediates autoproteolysis and subsequent attachment of the cleaved NTF and CTF fragments The adhesion family of G protein-coupled receptors (aGPCRs) is unique among all GPCR families with long N-termini and multiple domains that are implicated in cell-cell and cell-matrix interactions. Initially, aGPCRs in the human genome were phylogenetically classified into nine distinct subfamilies based on their 7TM sequence similarity. This phylogenetic grouping of genes into subfamilies was found to be in congruence in closely related mammals and other vertebrates as well. Over the years, aGPCR repertoires have been mapped in many species including model organisms, and, currently, there is a growing interest in exploring the pharmacological aspects of aGPCRs. Nonetheless, the aGPCR nomenclature has been highly diverse because experts in the field have used different names for different family members based on their characteristics (e.g., epidermal growth factor-seven-span transmembrane (EGF-TM7)), but without harmonization with regard to nomenclature efforts. In order to facilitate naming of orthologs and other genetic variants in different species in the future, the Adhesion-GPCR Consortium, together with the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification, proposed a unified nomenclature for aGPCRs. Here, we review the classification and the most recent/current nomenclature of aGPCRs and as well discuss the structural topology of the extracellular domain (ECD)/N-terminal fragment (NTF) that is comparable with this 7TM subfamily classification. Of note, we systematically describe the structural domains in the ECD of aGPCR subfamilies and highlight their role in aGPCR-protein interactions.
九种不同的粘附类G蛋白偶联受体(aGPCR)亚家族及其独特的N端结构域架构。该图还展示了所有aGPCR(除ADGRA1外)共有的细胞外结构特征,即GPCR自蛋白酶解诱导(GAIN)结构域,它介导自蛋白酶解以及随后裂解的N端片段(NTF)和C端片段(CTF)的连接。G蛋白偶联受体(aGPCR)的粘附家族在所有GPCR家族中独具特色,其N端较长且具有多个参与细胞间和细胞与基质相互作用的结构域。最初,基于其7次跨膜(7TM)序列相似性,人类基因组中的aGPCR在系统发育上被分为九个不同的亚家族。这种基因亚家族的系统发育分组在亲缘关系密切的哺乳动物和其他脊椎动物中也被发现是一致的。多年来,aGPCR库已在包括模式生物在内的许多物种中绘制出来,目前,人们对探索aGPCR的药理学方面的兴趣日益浓厚。尽管如此,aGPCR的命名一直高度多样化,因为该领域的专家根据其特征(例如,表皮生长因子 - 七次跨膜(EGF - TM7))对不同家族成员使用了不同的名称,但在命名工作上并未进行统一。为了便于未来对不同物种中的直系同源物和其他遗传变体进行命名,粘附类GPCR联盟与国际基础与临床药理学联合会受体命名与药物分类委员会共同提出了aGPCR的统一命名法。在此,我们回顾aGPCR的分类和最新/当前命名法,并讨论与该7TM亚家族分类可比的细胞外结构域(ECD)/N端片段(NTF)的结构拓扑。值得注意的是,我们系统地描述了aGPCR亚家族ECD中的结构域,并强调了它们在aGPCR - 蛋白质相互作用中的作用。